JamieL.DargartMD

Pediatric Hematology & Oncology • Toledo, OH

Physician

Join to view full profile

Dr. Dargart is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dargart's full profile

Already have an account?

Office
2142 N Cove Blvd
REN 4W
Toledo, OH 43606
Phone+1 419-291-9500

Fax+1 419-480-6858

Education & Training

Northwestern UniversityM.S., Clinical Investigation, 2009 - 2011
McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 2008 - 2011
McGaw Medical Center of Northwestern UniversityResidency, Pediatrics, 2005 - 2008
Case Western Reserve University School of MedicineClass of 2005

Certifications & Licensure

OH State Medical License 2011 - 2027
IL State Medical License 2005 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 Mar 26
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Start of enrollment: 2011 Sep 01
Completed
Phase 3
Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Jun 20
Active, not recruiting
Phase 3
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma Start of enrollment: 2014 Aug 01
Completed
Phase 2
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Start of enrollment: 2014 Oct 04
Active, not recruiting
Phase 3
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery Start of enrollment: 2014 Jul 11
Active, not recruiting
Phase 2, Phase 3
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Monozygotic twins diagnosed simultaneously with RAM immunophenotype acute myeloid leukemia.
Rolla Abu-Arja, Jamie L. Dargart, Rajinder P.S. Bajwa, Samir B. Kahwash, Jeffery J. Auletta
Pediatric Transplantation. 2018-12-01
6 citations
Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis.
Amy E. Armstrong, Jamie L. Dargart, Jennifer Reichek, David O. Walterhouse, Debora Matossian
Pediatric Blood & Cancer. 2014-05-01
27 citations
Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.
Jamie L. Dargart, Kamonwan Fish, Leo I. Gordon, Richard Longnecker, Osman Cen
Antiviral Research. 2012-07-01

Professional Memberships

American Society of Hematology - ASH
Member
Alpha Omega Alpha Honor Medical Society - AOA
Member
American Society of Clinical Oncology - ASCO
Member